193 related articles for article (PubMed ID: 15923275)
1. Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family.
McVety S; Li L; Gordon PH; Chong G; Foulkes WD
J Med Genet; 2006 Feb; 43(2):153-6. PubMed ID: 15923275
[TBL] [Abstract][Full Text] [Related]
2. Identification of a splicing enhancer in MLH1 using COMPARE, a new assay for determination of relative RNA splicing efficiencies.
Xu DQ; Mattox W
Hum Mol Genet; 2006 Jan; 15(2):329-36. PubMed ID: 16357104
[TBL] [Abstract][Full Text] [Related]
3. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E
Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550
[TBL] [Abstract][Full Text] [Related]
4. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.
Auclair J; Busine MP; Navarro C; Ruano E; Montmain G; Desseigne F; Saurin JC; Lasset C; Bonadona V; Giraud S; Puisieux A; Wang Q
Hum Mutat; 2006 Feb; 27(2):145-54. PubMed ID: 16395668
[TBL] [Abstract][Full Text] [Related]
5. A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects.
Tournier I; Vezain M; Martins A; Charbonnier F; Baert-Desurmont S; Olschwang S; Wang Q; Buisine MP; Soret J; Tazi J; Frébourg T; Tosi M
Hum Mutat; 2008 Dec; 29(12):1412-24. PubMed ID: 18561205
[TBL] [Abstract][Full Text] [Related]
6. A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families.
Stella A; Wagner A; Shito K; Lipkin SM; Watson P; Guanti G; Lynch HT; Fodde R; Liu B
Cancer Res; 2001 Oct; 61(19):7020-4. PubMed ID: 11585727
[TBL] [Abstract][Full Text] [Related]
7. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Sharp A; Pichert G; Lucassen A; Eccles D
Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
[TBL] [Abstract][Full Text] [Related]
8. Pathological exon skipping in an HNPCC proband with MLH1 splice acceptor site mutation.
Clarke LA; Veiga I; Isidro G; Jordan P; Ramos JS; Castedo S; Boavida MG
Genes Chromosomes Cancer; 2000 Dec; 29(4):367-70. PubMed ID: 11066084
[TBL] [Abstract][Full Text] [Related]
9. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
[TBL] [Abstract][Full Text] [Related]
10. In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects.
Lastella P; Surdo NC; Resta N; Guanti G; Stella A
BMC Genomics; 2006 Sep; 7():243. PubMed ID: 16995940
[TBL] [Abstract][Full Text] [Related]
11. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Am J Hum Genet; 2003 Nov; 73(5):1157-61. PubMed ID: 14526391
[TBL] [Abstract][Full Text] [Related]
12. ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs.
Shotelersuk V; Desudchit T; Tongkobpetch S
Int J Mol Med; 2004 Oct; 14(4):683-9. PubMed ID: 15375602
[TBL] [Abstract][Full Text] [Related]
13. Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene.
Tran VK; Takeshima Y; Zhang Z; Yagi M; Nishiyama A; Habara Y; Matsuo M
J Med Genet; 2006 Dec; 43(12):924-30. PubMed ID: 16738009
[TBL] [Abstract][Full Text] [Related]
14. PTEN c.511C>T nonsense mutation in a BRRS family disrupts a potential exonic splicing enhancer and causes exon skipping.
Suphapeetiporn K; Kongkam P; Tantivatana J; Sinthuwiwat T; Tongkobpetch S; Shotelersuk V
Jpn J Clin Oncol; 2006 Dec; 36(12):814-21. PubMed ID: 17043057
[TBL] [Abstract][Full Text] [Related]
15. Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer.
Baert-Desurmont S; Buisine MP; Bessenay E; Frerot S; Lovecchio T; Martin C; Olschwang S; Wang Q; Frebourg T
Eur J Hum Genet; 2007 Mar; 15(3):383-6. PubMed ID: 17228328
[TBL] [Abstract][Full Text] [Related]
16. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
[TBL] [Abstract][Full Text] [Related]
17. [The analysis for mRNA mutation of MLH1, MSH2 genes and the gene diagnosis for hereditary nonpolyposis colorectal cancer].
Wang CF; Zhou XY; Zhang TM; Sun MH; Xu Y; Shi DR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):32-6. PubMed ID: 16456782
[TBL] [Abstract][Full Text] [Related]
18. Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds.
Nyström-Lahti M; Holmberg M; Fidalgo P; Salovaara R; de la Chapelle A; Jiricny J; Peltomäki P
Genes Chromosomes Cancer; 1999 Dec; 26(4):372-5. PubMed ID: 10534773
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
20. Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2.
Betz B; Theiss S; Aktas M; Konermann C; Goecke TO; Möslein G; Schaal H; Royer-Pokora B
J Cancer Res Clin Oncol; 2010 Jan; 136(1):123-34. PubMed ID: 19669161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
